Study to Assess Effectiveness and Adverse Events of JUVEDERM VOLBELLA With Lidocaine Injection in Correcting Infraorbital Hollowing in Chinese Adult Participants

PHASE3CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

October 19, 2021

Primary Completion Date

November 29, 2023

Study Completion Date

November 29, 2023

Conditions
Infraorbital Hollowing
Interventions
DEVICE

VOLBELLA with Lidocaine

Facial Injection

Trial Locations (7)

100034

Peking University First Hospital /ID# 227593, Xicheng District

100730

Beijing Hospital /ID# 227588, Beijing

Peking Union Medical College Hospital /ID# 227590, Beijing

200040

Huashan Hospital, Fudan University /ID# 227591, Shanghai

210008

Nanjing Drum Tower Hospital /ID# 241042, Nanjing

210009

Zhongda Hospital Southeast University /ID# 241040, Nanjing

266000

The Affiliated Hospital of Qingdao University /ID# 227592, Qingdao

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY